Karen Murphy Santiago
Controller, Bristol-Myers Squibb.
Companies
- Catalent Pharma SolutionsVP & Chief Accounting Officer Sep 21, 2022 to Aug 3, 20231
- Bristol-Myers SquibbController Feb 21, 2018 to Mar 16, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY16,704 shares3$1.0M at $60.95Mar 14, 2022
Catalent Pharma Solutions CTLT4,763 shares4Aug 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 1, 2023Granted 2,342 shares of Catalent Pharma Solutions4
- Sep 19, 2022Granted 1,681 shares of Catalent Pharma Solutions5
- Sep 19, 2022Granted 740 shares of Catalent Pharma Solutions5
- Mar 14, 2022Sold 6,577 shares at $69.19 of Bristol-Myers Squibb3
- Mar 10, 2022Shares withheld for tax 4,500 shares at $68.42 of Bristol-Myers Squibb6
- Mar 10, 2022Other 3,292 shares of Bristol-Myers Squibb6
- Mar 10, 2022Exercised options 6,939 shares of Bristol-Myers Squibb6
- Mar 10, 2022Shares withheld for tax 464 shares at $68.42 of Bristol-Myers Squibb6
- Mar 10, 2022Other 129 shares of Bristol-Myers Squibb6
- Mar 10, 2022Exercised options 1,154 shares of Bristol-Myers Squibb6
- Mar 10, 2022Shares withheld for tax 468 shares at $68.42 of Bristol-Myers Squibb6
- Mar 10, 2022Other 151 shares of Bristol-Myers Squibb6
- Mar 10, 2022Exercised options 1,141 shares of Bristol-Myers Squibb6
- Mar 10, 2022Shares withheld for tax 545 shares at $68.42 of Bristol-Myers Squibb6
- Mar 10, 2022Other 351 shares of Bristol-Myers Squibb6
- Mar 10, 2022Exercised options 1,156 shares of Bristol-Myers Squibb6
- Mar 10, 2022Shares withheld for tax 246 shares at $68.42 of Bristol-Myers Squibb6
- Mar 10, 2022Other 10 shares of Bristol-Myers Squibb6
- Mar 10, 2022Exercised options 683 shares of Bristol-Myers Squibb6
- Jul 1, 2021Shares withheld for tax 547 shares at $66.56 of Bristol-Myers Squibb7
- Jul 1, 2021Exercised options 1,069 shares of Bristol-Myers Squibb7
- Mar 10, 2021Shares withheld for tax 1,538 shares at $60.93 of Bristol-Myers Squibb8
- Mar 10, 2021Other 797 shares of Bristol-Myers Squibb8
- Mar 10, 2021Exercised options 4,093 shares of Bristol-Myers Squibb8
- Mar 10, 2021Shares withheld for tax 365 shares at $60.93 of Bristol-Myers Squibb8
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Mar 14, 2022 | BMY | Sale | $455.1K | −13.7% | +98.8% | −2.1% |
| May 16, 2019 | BMY | Sale | $145.8K | +26.8% | +141.5% | −36.5% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARBristol-Myers Squibb, Controller
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 21, 2022
- 6SEC EDGARForm 4 filed Mar 14, 2022
- 7SEC EDGARForm 4 filed Jul 6, 2021
- 8SEC EDGARForm 4 filed Mar 12, 2021